• September 30, 2017
    Elimination of Interference by Differential Mobility Spectrometry for Quantitation of the Biologic Rituximab in Human Plasma by LC-MS/MS
  • September 8, 2017
    Next‐Day Residual Effects of Flibanserin on Simulated Driving Performance in Premenopausal Women
  • April 19, 2017
    Quantitative Analysis of Protein Biotherapeutics: Recent Advancements in LC-MS/MS Technology for Improved Selectivity and Sensitivity
  • June 14, 2016
    Kansas City Business Journal: Vince & Associates opens state-of-the-art research facility
  • October 15, 2015
    Whitepaper: Maximizing Early Development Clinical Trials with Adaptive Study Designs